Matheus Montecasciano
Souto Correa AdvogadosAnderson Ribeiro leads the life sciences practice at Souto Correa Advogados, which stands out for its expertise in sector-related regulatory issues. Present in all key segments, from pharmaceuticals and medical devices, to food and healthcare, the team is particularly well equipped to handle matters concerning rare diseases and gene therapies, under the leadership of Ribeiro, rated for his 'strategic vision, deep knowledge of laws and ANVISA regulations'. In addition to regulatory issues, its service offering also covers pricing, contracts, clinical trails, and transactions. A former in-house counsel for major pharmaceutical companies, Paulo Rosito focuses on IP-related issues and commercial matters. Associate Matheus Montecasciano is the go-to for food and drug law issues, and has represented a number of clients in public procurement and administrative proceedings before ANVISA.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Under the leadership of Anderson Ribeiro, the firm brings unique expertise and practicality to legal consultations. Anderson's vast knowledge of ANVISA's day-to-day operations and industry trends means that he always adds a lot of value with his points. Furthermore, their answers are always objective, didactic and practical, often using an executive summary on the point under study.'
‘With the incorporation of Anderson Ribeiro as the lead partner for the life sciences practice, Souto Correa has escalated to a top level in the life sciences field. Anderson leads an excellent team of pharma sophisticated lawyers knowledgeable in this practice, with the particular twist of having in the team Paulo Rosito, who provides a different approach to the matters, knowing exactly what the client is expecting to receive.’
‘They know the laws and regulations, they have an extensive practice in this field.’
‘The life sciences practice is very competent, up to date with innovations and ready to develop strategies for companies to act with legal certainty. They keep up-to-date with government relations in a very attentive, ethical and competent way.’
‘Anderson Ribeiro- strategic vision, deep knowledge of laws and ANVISA regulations, skilled negotiator, and respected by regulatory agents. Matheus Montecasciano - very available, conciliatory, clear, and has very good knowledge of ANVISA laws and regulations.’
‘The Souto Correa team stands out for its excellent service and expertise. As a client, I realise that there is a personalised service and I have always been served with efficiency and professionalism. The lawyers are highly qualified.’
‘Matheus Montecasciano and Anderson Ribeiro stand out; they are experts and experienced in life sciences and always exceed my expectations, providing innovative and effective legal solutions.’
‘Matheus Montecasciano, Anderson Ribeiro, and Ana Carolina Paz. The three professionals have knowledge, experience and agility. In addition to being trained professionals, they are friendly, act ethically and transparently, guiding our decisions wisely.'
Key clients
- BioMarin Pharmaceutical
- Laborclin
- Interfarma
- IFF / Danisco
- Vertex
- Sindusfarma
- Teva
- Janssen Cilag / Johnson & Johnson
- Laboratório Catarinense
- Greencare
Work highlights
- Assisting José Seripieri Filho with the acquisition of Amil from US health insurance company UnitedHealth Group (UHG), for R$11bn.
- Advising Vertex on the Trikafta’s Health Technology Assessment (HTA) procedure before the Ministry of Health (MoH).
- Assisted Novo Nordisk with expanding its manufacturing facilities in Brazil by developing necessary contractual protections.
Lawyers
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Anderson Ribeiro
Souto Correa AdvogadosPractice head
The lawyer(s) leading their teams.
Anderson Ribeiro